ITMCTR2200005494
Recruiting
Phase 1
Short-term and long-term efficacy and safety evaluation of acupoint catgut embedding in the simple obesity: a randomized controlled double-blind trial
The Fifth Affiliated Hospital of Southern Medical University0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The Fifth Affiliated Hospital of Southern Medical University
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Meet the diagnostic criteria for being overweight or obese;
- •2\.Aged 18 to 60 years;
- •3\.Have not received any other weight\-loss treatment within the last 3 months;
- •4\.Volunteered to participate in the study and signed the informed consent.
Exclusion Criteria
- •1\.Allergic to alcohol or PGLA;
- •2\.Pregnant or lactation patients;
- •3\.Secondary obesity, as follows thalamus, pituitary disease, hypothyroidism, increased cortisol, increased insulin, changes in gonadal secretion and drugs caused by secondary obesity patients;
- •4\.Complicated with serious cardiovascular and cerebrovascular diseases, liver and kidney diseases, mental or emotional disorders unable to cooperate;Local skin damage or infection;
- •5\.Patients with abnormal coagulation function.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Evaluation of Long-term efficacy, safety and predictors of Adalimumab in Crohn's disease: Japanese multicenter cohort study (ADJUST study)JPRN-UMIN000014708IBD Center, Sapporo Kosei General Hospital500
Active, not recruiting
Phase 1
ong Term Follow-up Study of AAVAnc80-hOTOF Gene TherapyOtoferlin gene-mediated hearing lossTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]CTIS2024-512584-31-00Akouos Inc.14
Active, not recruiting
Not Applicable
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis.EUCTR2009-016119-38-PLAmgen Inc220
Active, not recruiting
Not Applicable
Safety and Efficacy of AMG 827 in Subjects With RARheumatoid arthritisMedDRA version: 13.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2009-016119-38-GBAmgen Inc220
Active, not recruiting
Not Applicable
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis.Rheumatoid arthritisMedDRA version: 12.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2009-016119-38-BGAmgen Inc220